Experienced in Atypical Teratoid Rhabdoid Tumor (ATRT)

Dr. Rafael A. Ortiz

Neuroradiology | Vascular Surgery | Interventional Radiology
White Plains Physician Services PC
122 Maple Ave, 
White Plains, NY 
Offers Telehealth
Experienced in Atypical Teratoid Rhabdoid Tumor (ATRT)
White Plains Physician Services PC
122 Maple Ave, 
White Plains, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Rafael Ortiz is a Neuroradiologist and a Vascular Surgeon in White Plains, New York. Dr. Ortiz is rated as an Experienced provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). His top areas of expertise are Brain Aneurysm, Stroke, Apoplexy, Stent Placement, and Transmyocardial Revascularization.

His clinical research consists of co-authoring 47 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neuroradiology
Vascular Surgery
Interventional Radiology
Licenses
Radiology in NY
Hospital Affiliations
White Plains Hospital Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Cigna
  • EPO
  • HMO
  • PPO

Locations

WHITE PLAINS PHYSICIAN SERVICES PC
122 Maple Ave, White Plains, NY 10601

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

LUNAR: Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure
LUNAR: Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure
Enrollment Status: Completed
Publish Date: October 21, 2024
Intervention Type: Drug, Device
Study Drug: Immune checkpoint inhibitors or docetaxel
Study Phase: Phase 3
Phase I/II Trial of Repeated Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Newly Diagnosed Glioblastoma Multiforme
Phase I/II Trial of Repeated Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Newly Diagnosed Glioblastoma Multiforme
Enrollment Status: Completed
Publish Date: January 30, 2024
Intervention Type: Drug
Study Drug: Bevacizumab
Study Phase: Phase 1/Phase 2
Phase 1 Trial of Super-selective Intra-arterial Cerebral Infusion of Trastuzumab After Blood-Brain Barrier Disruption for the Treatment of Cerebral Metastases of HER2/Neu Positive Breast Cancer
Phase 1 Trial of Super-selective Intra-arterial Cerebral Infusion of Trastuzumab After Blood-Brain Barrier Disruption for the Treatment of Cerebral Metastases of HER2/Neu Positive Breast Cancer
Enrollment Status: Terminated
Publish Date: November 03, 2021
Intervention Type: Drug
Study Drug: Intra-arterial Cerebral Infusion of Trastuzumab
Study Phase: Phase 1
Phase I Trial of Super-Selective Intraarterial Infusion of Cetuximab (Erbitux) With or Without Radiation Therapy for the Treatment of Unresectable Recurrent Squamous Cell Carcinoma of the Head and Neck
Phase I Trial of Super-Selective Intraarterial Infusion of Cetuximab (Erbitux) With or Without Radiation Therapy for the Treatment of Unresectable Recurrent Squamous Cell Carcinoma of the Head and Neck
Enrollment Status: Terminated
Publish Date: November 03, 2021
Intervention Type: Drug
Study Drug: Cetuximab
Study Phase: Phase 1
View 3 Less Clinical Trials

47 Total Publications

Impact of Cerebral Revascularization on Pial Collateral Flow in Patients With Unilateral Moyamoya Disease Using Quantitative Magnetic Resonance Angiography.
Impact of Cerebral Revascularization on Pial Collateral Flow in Patients With Unilateral Moyamoya Disease Using Quantitative Magnetic Resonance Angiography.
Journal: Neurosurgery
Published: October 17, 2023
Similar Doctors
Distinguished in Atypical Teratoid Rhabdoid Tumor (ATRT)
Dr. Fabio M. Iwamoto
Neurology
Distinguished in Atypical Teratoid Rhabdoid Tumor (ATRT)
Dr. Fabio M. Iwamoto
Neurology

Trustees Of Columbia University In The City Of New York

710 W 168th St, 
New York, NY 
 (15.6 miles away)
212-305-3870
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Fabio Iwamoto is a Neurologist in New York, New York. Dr. Iwamoto is rated as an Elite provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.

Distinguished in Atypical Teratoid Rhabdoid Tumor (ATRT)
Dr. Andrew B. Lassman
Neurology
Distinguished in Atypical Teratoid Rhabdoid Tumor (ATRT)
Dr. Andrew B. Lassman
Neurology

Trustees Of Columbia University In The City Of New York

51 W 51st St, 
New York, NY 
 (21.4 miles away)
212-326-5705
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Andrew Lassman is a Neurologist in New York, New York. Dr. Lassman is rated as an Elite provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, and Gliomatosis Cerebri.

Distinguished in Atypical Teratoid Rhabdoid Tumor (ATRT)
Dr. Eli L. Diamond
Neurology
Distinguished in Atypical Teratoid Rhabdoid Tumor (ATRT)
Dr. Eli L. Diamond
Neurology

Memorial Neurology Group

160 E 53rd St, 
New York, NY 
 (21.3 miles away)
212-639-2000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Eli Diamond is a Neurologist in New York, New York. Dr. Diamond is rated as an Elite provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). His top areas of expertise are Erdheim-Chester Disease, Glioblastoma, Astrocytoma, Brain Tumor, and Awake Craniotomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ortiz's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 29 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile